Breast Cancer: Current Research
黑料网
Our Group organises 3000+ Global Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ 黑料网 Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
黑料网 Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Citations : 114
Indexed In
- RefSeek
- Hamdard University
- EBSCO A-Z
- Publons
- ICMJE
Useful Links
Recommended Journals
Related Subjects
Share This Page
Adverse effects of non-hormonal pharmacological interventions in breast cancer survivors, suffering from hot flashes: A systematic review and meta-analysis
5th World Congress on Breast Cancer
Jill Brook Hervik
Vestfold Hospital Trust, Norway
ScientificTracks Abstracts: Breast Can Curr Res
DOI:
Abstract
Purpose: To access frequency and severity of adverse effects (AE) of non-hormonal drugs (NHD) for hot flashes in breast cancer survivors compared to controls and analyze adverse effect risk by reviewing published randomized trials. Methods: Five data bases were searched, trials were included where participants were breast cancer survivors suffering from hot flashes, treatment was self-administered venlafaxine, gabapentin or clonidine, and AE芒�?�?s were reported. AE frequency and severity was graded and a meta-analysis with sub-group analyses was conducted. Results: 12/49 studies were included, 1467 participants experienced 772 adverse effects, 81% from treatment groups and 19% from control groups. 67% of AE芒�?�?s was graded as mild and 33% as moderate. The frequency of AE for NHD was overall significant versus placebo. AE frequency and severity increased at higher doses for venlafaxine and gabapentin compared to placebo. Conclusion: The odds for experiencing AE was significantly higher in patients randomized to high dose NHD than those randomized to controls, including placebo, low dose medication and acupuncture. These therapies should be considered as a potential treatment alternative.Biography
Jill Brook Hervik is currently working as a Physiotherapist, Acupuncturist and Researcher in hospital pain clinic (Vestfold Hospital Trust, Norway). Her areas of interest include integrative medicine, the importance of detailed clinical examination, multidisciplinary approach to pain syndromes and long term side effects of breast cancer treatments. She has published eight different articles in reputable medical journals.
Email: jill.hervik@siv.no
